Meta-analysis of 15 RCTs (818 patients with AERD subgroups): biologics vs placebo improved nasal polyp score (MD −1.33), SNOT-22 (MD −19.16), smell, ACQ-5 (MD −0.90) and FEV1 (MD 0.29 L), all exceeding minimal clinically important differences.
Meta-analysisn = 818
Du et al. Biologics and Selected Upper- and Lower-Airway Outcomes in AERD Subgroups: A Systematic Review and Meta-Analysis